BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//talks.cam.ac.uk//v3//EN
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:19700329T010000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:19701025T020000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
CATEGORIES:Department of Pharmacology Seminar Series
SUMMARY:Redirecting innate immune mechanisms against aggre
 gated proteins - Dr William McEwan\, University of
  Cambridge UK Dementia Research Institute
DTSTART;TZID=Europe/London:20241122T160000
DTEND;TZID=Europe/London:20241122T170000
UID:TALK222076AThttp://talks.cam.ac.uk
URL:http://talks.cam.ac.uk/talk/index/222076
DESCRIPTION:Venue: Department of Pharmacology\, Seminar Room\,
  Level 2\n\nBiography: A Sir Henry Dale Fellow\, P
 rof Will McEwan joined the UK DRI in 2017 followin
 g his postdoctoral training at the MRC Laboratory 
 of Molecular Biology in Cambridge. Will trained as
  a viral immunologist and during his postdoc co-di
 scovered and characterised the novel antibody rece
 ptor TRIM21. At the UK DRI at Cambridge\, he will 
 utilise his expertise in viral infection and apply
  it in the context of protein misfolding in neurod
 egenerative disease.\n\nZoom: https://cam-ac-uk.zo
 om.us/j/86412712924?pwd=I7YBqbdQNaEixwJucXK5UKPcJ6
 OxoB.1
LOCATION:Seminar Room (Level 2)\, Dept of Pharmacology 
CONTACT:Daniel Paolo Juan
END:VEVENT
END:VCALENDAR